Spherical Cancer Models in Tumor Biology

References 188

1. 1.

   This reference’s wording can’t be shown under the paper’s licence.

   Not in our library

2. 2.

   This reference’s wording can’t be shown under the paper’s licence.

   Not in our library

3. 3.

   This reference’s wording can’t be shown under the paper’s licence.

   Not in our library

4. 4.

   This reference’s wording can’t be shown under the paper’s licence.

   Not in our library

5. 5.

   This reference’s wording can’t be shown under the paper’s licence.

   Not in our library

6. 6.

   This reference’s wording can’t be shown under the paper’s licence.

   Not in our library

7. 7.

   This reference’s wording can’t be shown under the paper’s licence.

   Not in our library

8. 8.

   This reference’s wording can’t be shown under the paper’s licence.

   Not in our library

9. 9.

   This reference’s wording can’t be shown under the paper’s licence.

   Not in our library

10. 10.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

11. 11.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

12. 12.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

13. 13.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

14. 14.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

15. 15.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

16. 16.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

17. 17.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

18. 18.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

19. 19.
    Disaggregation and invasion of ovarian carcinoma ascites spheroids · 2006

    No notice
20. 20.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

21. 21.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

22. 22.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

23. 23.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

24. 24.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

25. 25.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

26. 26.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

27. 27.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

28. 28.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

29. 29.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

30. 30.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

31. 31.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

32. 32.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

33. 33.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

34. 34.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

35. 35.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

36. 36.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

37. 37.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

38. 38.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

39. 39.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

40. 40.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

Cited by papers we hold 23

• Patient-derived tumor organoids: a new avenue for preclinical research and precision medicine in oncology · 2024
  No notice
• Three-dimensional in vitro culture models in oncology research · 2022
  No notice
• Understanding cell‐cell communication and signaling in the colorectal cancer microenvironment · 2021
  No notice
• 3D Bioprinted cancer models: Revolutionizing personalized cancer therapy · 2021
  No notice
• Challenges of applying multicellular tumor spheroids in preclinical phase · 2021
  No notice
• Tumor-on-a-chip: from bioinspired design to biomedical application · 2021
  No notice
• 3D Cell Culture Models as Recapitulators of the Tumor Microenvironment for the Screening of Anti-Cancer Drugs · 2021
  No notice
• Organoid and Spheroid Tumor Models: Techniques and Applications · 2021
  No notice
• Three-Dimensional Spheroids as In Vitro Preclinical Models for Cancer Research · 2020
  No notice
• 3D Tumor Models and Their Use for the Testing of Immunotherapies · 2020
  No notice
• Tumor Cell Invasion in Glioblastoma · 2020
  No notice
• Microtechnology-based methods for organoid models · 2020
  No notice
• Modeling neoplastic disease with spheroids and organoids · 2020
  No notice
• The effect of 2D and 3D cell cultures on treatment response, EMT profile and stem cell features in head and neck cancer · 2019
  No notice
• Cocultures of human colorectal tumor spheroids with immune cells reveal the therapeutic potential of MICA/B and NKG2A targeting for cancer treatment · 2019
  No notice
• The mitochondrial citrate carrier, SLC25A1, drives stemness and therapy resistance in non-small cell lung cancer · 2018
  No notice
• Cancer stem cells as key drivers of tumour progression · 2018
  No notice
• EMT and stemness: flexible processes tuned by alternative splicing in development and cancer progression · 2017
  No notice
• Modeling tumor cell adaptations to hypoxia in multicellular tumor spheroids · 2017
  No notice
• High-Content Monitoring of Drug Effects in a 3D Spheroid Model · 2017
  No notice

and 3 more

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.